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Herpes simplex virus (HSV) encephalitis (HSVE) is the commonest cause of death in cases of sporadic 
encephalitis in humans (Johnston, 1998) with relapse occurring in approximately 12% of patients 
(Skoldenberg et al., 2006). Whilst commonly attributed to viral reactivation, it is increasingly recognised 
that a proportion of ‘relapses’ are due to anti-NMDA receptor encephalitis (NMDARE), a treatable 
autoimmune disorder caused by IgG autoantibodies against the NR1 subunit of the N-methyl-D-
aspartate (NMDA) receptor. While the proportion of clinical relapses from HSVE attributable to 
NMDARE remains unknown, a recent study found 30% of post HSVE patients had anti-NMDA receptor 
antibodies in serum, or CSF (Pruss et al., 2012). Affective symptoms have been described as a presenting 
symptom of HSVE, as well as a sequel (McGrath et al., 1997, Leypoldt et al., 2013), although the 
underlying mechanisms have not been elucidated. We report the case of a manic episode associated 
with transient NMDA receptor autoimmunity occurring as a sequel to HSVE. 
 
A 37-year-old male with an unremarkable medical history was admitted to hospital with headaches and 
subsequently suffered a generalised seizure and cardio-respiratory arrest. MRI revealed acute 
restricted diffusion in the right mesial temporal lobe and a cerebrospinal fluid (CSF) sample was positive 
for HSV type 1 (HSV-1). He was treated with intravenous acyclovir and discharged with residual 
symptoms of headache, fatigue and bilateral tremor of the upper limbs. 
 
One month later he was brought back to hospital with a four-day history of paranoia and insomnia. On 
arrival he was distractible and preoccupied with colours and numbers and highly agitated, requiring 
intramuscular sedation. Neurological exam revealed gaze impersistence and saccadic intrusion of 
smooth pursuit, fine tremor with superimposed myoclonic jerks and subtle perioral myoclonus. 
Neuropsychiatric assessment revealed manic symptoms including social disinhibition, elation, 
increased self-esteem and tangential thoughts. 
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Initial blood results revealed elevated C-reactive protein (23 mg/L) and neutrophil count (7.9x109/L). 
Serum anti-NMDA receptor antibody using a live cell-based assay was low positive (scoring 1.5 on a 0-
4 scale at 1:20 dilution and 0.5 at 1:100 dilution). Serum anti-VGKC and onconeural antibody screen 
were negative. CSF revealed elevated protein (784 mg/dL) and white blood cells (9 cells/µ), as well as 
unmatched oligoclonal bands. A CSF and serum viral screen, which included HSV-1 PCR, was negative. 
 
MRI head revealed signal abnormality, with swelling within the right anteromesial temporal lobe and 
dorsal frontal lobe extending into gyrus rectus and posteriorly into the ipsilateral parietal and occipital 
lobes with blurring of grey-white matter differentiation in keeping with recent HSVE. EEG revealed a 
delta-brush like appearance, a pattern reported to be highly specific for NMDARE (Schmitt et al., 2012). 
 
He was commenced on IV acyclovir, prior to excluding a viral aetiology, thereafter treated with regular 
clonazepam 1mg BD, leading to partial reduction of his manic symptoms and he was discharged after 
two weeks. Repeat serum anti-NMDA receptor antibody assay was negative and EEG was normal, whilst 
MRI showed resolving signal hyperintensity and reduced swelling, with some persisting signal 
abnormality in the right anteromesial temporal lobe. Repeat neuropsychiatric assessment revealed 
resolution of manic/psychotic symptoms and cognitive impairment (see figure 1).  
 
The case expands the likely clinical manifestations of post-HSV NMDA receptor autoimmunity, as well 
as suggesting a plausible explanation for some of the cognitive and affective changes occurring after 
HSVE.  
 
Evidence supporting the pathogenic relevance of NMDA receptor autoimmunity includes the 
characteristic delta brush-like waves, unmatched oligoclonal bands and temporal association between 
antibody and affective status. Possible mechanisms by which HSV infection could cause neuronal 
autoimmunity include a) limbic damage leading to exposure of NMDA receptor epitopes triggering a 
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second immune response and b) molecular mimicry. An alternative explanation is that the patient’s 
neuropsychiatric symptoms emerged as a sequel to structural damage from HSV infection and the 
autoantibodies reflect an epiphenomenon, although this would not account for the delayed and 
transient nature of the manic episode. 
 
Leypoldt et al. (2013) reported a case of NMDARE following HSVE, who presented with predominantly 
manic symptoms, and who recovered with steroid treatment. Notably, our patient did not receive 
immunotherapy, but recovered as serum anti-NMDA receptor antibodies became undetectable. The 
incidence of psychosis and mania is greatly increased following encephalitis (Granerod et al., 2017) 
.Mechanisms underlying the development of postencephalitic psychiatric disorders are likely to be 
heterogeneous, however we suggest CNS autoimmunity should be considered a potential aetiological 
factor. 
 
Within psychiatry, there has been recent interest in the role of NMDA receptor autoimmunity in 
‘primary’ psychiatric disorders (Al-Diwani et al., 2017); specifically a temporal association between 
NMDAR (NR2) autoimmunity and mania has been reported in the context of bipolar disorder (Dickerson 
et al., 2012). It is notable that evidence of HSV infection in bipolar affective disorder is associated with 
poor cognitive function (Dickerson et al., 2004). Future research is indicated to explore whether NMDA 
receptor autoimmunity may be a mechanistic ‘missing link’ connecting HSV infection and 
cognitive/affective symptoms in psychiatric disorders, including bipolar affective disorder. 
This case suggests that patients developing mood symptoms, and in particular mania, following HSV 
encephalitis should be investigated with NMDA receptor autoantibody testing.  
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Figure 1: EEG and MRI on day five of admission (left) and at follow up (right) with time course of 
events. A) EEG showing dominant posterior reactive alpha background rhythm at 10-11 Hz. In addition 
there are frequent runs of right temporal delta waves, with superimposed serrated activity in the 
alpha and beta range of delta-brush like appearance which resolved at follow-up 24 weeks later. 
Spectral analysis over highlighted segment demonstrating power predominantly in the beta, alpha 
and delta frequency bands. B) Coronal Fluid Attenuation Inversion Recovery Sequences (FLAIR) and 
axial T2 showing initial swelling and signal hyperintensity within the right temporal lobe which reduced 
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at follow-up 15 weeks later, with persisting chronic encephalomalacia in the anterior right temporal 
lobe. C) Timeline of events from initial presentation including hospital admission, treatment, Herpes 
Simplex Virus (HSV) and anti-N-methyl-D-aspartate receptor (NMDAR) antibody status. Also plotted 
are total Positive and Negative Symptom Scale (PANSS), Young Mania Rating Scale (YMRS), and 
Addenbrooke's Cognitive Examination-Revised (ACE-R) scores. 
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